|
|
Substance Name: Levosulpiride [INN]
RN: 23672-07-3
UNII: JTG7R315LK
InChIKey: BGRJTUBHPOOWDU-NSHDSACASA-N
Classification Code
- Drug / Therapeutic Agent
Molecular Formula
- C15-H23-N3-O4-S
Molecular Weight
- 341.4297
* denotes mobile formatted website
Links to Resources
NLM Resources (File Locators)
Other Resources (Internet Locators)
Search for this InChIKey on the Web
Names and Synonyms
Name of Substance
- Levosulpiride
- Levosulpiride [INN]
Synonyms
- (-)-N-(((S)-1-Ethyl-2-pyrrolidinyl)methyl)-5-sulfamoyl-o-anisamide
- (S)-(-)-N-((1-Ethyl-2-pyrrolidinyl)methyl)-5-sulfamoyl-o-anisamide
- Benzamide, N-((1-ethyl-2-pyrrolidinyl)methyl)-2-methoxy-5-sulfamoyl-, S-(-)-
- Levopraid
- Levosulpirida
- Levosulpirida [INN-Spanish]
- Levosulpiride
- Levosulpiridum
- Levosulpiridum [INN-Latin]
- Nexipride
- RV-12309
- S-(-)-N-(1-Ethyl-2-pyrrolidinomethyl)-2-methoxy-5-sulfamoylebenzamide
- S-(-)-Sulpiride
- UNII-JTG7R315LK
Systematic Names
- (-)-N-(((S)-1-Ethyl-2-pyrrolidinyl)methyl)-5-sulfamoyl-o-anisamide
- Benzamide, 5-(aminosulfonyl)-N-((1-ethyl-2-pyrrolidinyl)methyl)-2-methoxy-, (S)-
- o-Anisamide, N-((1-ethyl-2-pyrrolidinyl)methyl)-5-sulfamoyl-, (S)-(-)-
Registry Numbers
CAS Registry Number
- 23672-07-3
FDA UNII
- JTG7R315LK
System Generated Number
- 0023672073
Structure Descriptors
InChI
InChI=1S/C15H23N3O4S/c1-3-18-8-4-5-11(18)10-17-15(19)13-9-12(23(16,20)21)6-7-14(13)22-2/h6-7,9,11H,3-5,8,10H2,1-2H3,(H,17,19)(H2,16,20,21)/t11-/m0/s1InChIKey
BGRJTUBHPOOWDU-NSHDSACASA-NSmiles
CCN1CCC[C@H]1CNC(=O)Toxicity
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
mouse | LD50 | intraperitoneal | 170mg/kg (170mg/kg) | European Journal of Medicinal Chemistry--Chimie Therapeutique. Vol. 17, Pg. 437, 1982. | |
mouse | LD50 | oral | 2450mg/kg (2450mg/kg) | Drugs of the Future. Vol. 12, Pg. 944, 1987. | |
rabbit | LD50 | intravenous | 42mg/kg (42mg/kg) | Drugs of the Future. Vol. 12, Pg. 944, 1987. | |
rabbit | LD50 | oral | > 1500mg/kg (1500mg/kg) | Drugs of the Future. Vol. 12, Pg. 944, 1987. | |
rat | LD50 | intraperitoneal | 270mg/kg (270mg/kg) | Drugs of the Future. Vol. 12, Pg. 944, 1987. | |
rat | LD50 | intravenous | 53mg/kg (53mg/kg) | Drugs of the Future. Vol. 12, Pg. 944, 1987. | |
rat | LD50 | oral | 2600mg/kg (2600mg/kg) | Drugs of the Future. Vol. 12, Pg. 944, 1987. |